APA (7th ed.) Citation

Mirella Czapska, Kamila Babkiewicz, Szczepan Pabis, & Katarzyna Skórzyńska-Dziduszko. (2018). Sotagliflozin, an inhibitor of sodium-glucose cotransporters 1 and 2 (SGLT1/2), as a new therapeutic approach for patients with type 1 diabetes mellitus. Kazimierz Wielki University.

Chicago Style (17th ed.) Citation

Mirella Czapska, Kamila Babkiewicz, Szczepan Pabis, and Katarzyna Skórzyńska-Dziduszko. Sotagliflozin, an Inhibitor of Sodium-glucose Cotransporters 1 and 2 (SGLT1/2), as a New Therapeutic Approach for Patients with Type 1 Diabetes Mellitus. Kazimierz Wielki University, 2018.

MLA (9th ed.) Citation

Mirella Czapska, et al. Sotagliflozin, an Inhibitor of Sodium-glucose Cotransporters 1 and 2 (SGLT1/2), as a New Therapeutic Approach for Patients with Type 1 Diabetes Mellitus. Kazimierz Wielki University, 2018.